Dumping Syndrome and Quality of Life After Vagus Nerve-preserving Distal Gastrectomy
VNP
Incidence of Dumping Syndrome After Laparoscopic Vagus Nerve-preserving Distal Gastrectomy for Early Gastric Cancer
1 other identifier
observational
100
1 country
1
Brief Summary
There is no consensus on what type of function-preserving gastrectomy can provide the best patient quality of life (QOL). This study aims to evaluate the incidence of dumping syndrome after vagus nerve-preserving distal gastrectomy (VPNDG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 9, 2017
CompletedFirst Submitted
Initial submission to the registry
March 17, 2019
CompletedFirst Posted
Study publicly available on registry
March 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2020
CompletedMarch 9, 2021
March 1, 2021
2 years
March 17, 2019
March 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Dumping syndrome
Sigstad score of equal or more than 7
1 year
Secondary Outcomes (3)
EORTC C-30/STO22
3 months, 6 months, 1 year
Postoperative complication
3 months, 6 months, 1 year
Incidence of gallstones
1 year
Other Outcomes (4)
Operative time
Immediately after operation
Estimated blood loss
Immediately after operation
Time to first flatus
Within 1 week
- +1 more other outcomes
Study Arms (1)
Vagus nerve preserving group
Patients who underwent vagus nerve-preserving distal gastrectomy for early gastric cancer
Interventions
Laparoscopic distal gastrectomy with the preservation of the celiac and hepatic branch of the vagus nerve.
Eligibility Criteria
Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach
You may qualify if:
- Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach planned to undergo laparoscopic vagus nerve-preserving distal gastrectomy
You may not qualify if:
- Sacrificed vagus nerve
- Anastomosis other than Roux-en Y gastrojejunostomy or uncut Roux-en Y gastrojejunostomy
- conversion to an open procedure
- combined resection of other organs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 17, 2019
First Posted
March 19, 2019
Study Start
August 9, 2017
Primary Completion
August 19, 2019
Study Completion
August 20, 2020
Last Updated
March 9, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share
There is currently no plan to share our IPD with other researchers unless needed.